NO2019037I1 - pegvaliase - Google Patents

pegvaliase

Info

Publication number: NO2019037I1
Authority: NO; Norway
Prior art keywords: pegvaliase
Prior art date: 2007-05-25

Application number

NO2019037C

Other languages

English (en)

Original Assignee

Biomarin Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-05-25

Filing date

2019-10-16

Publication date

2019-10-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39868905&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2019037(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2019-10-16 Application filed by Biomarin Pharm Inc filed Critical Biomarin Pharm Inc

2019-10-16 Publication of NO2019037I1 publication Critical patent/NO2019037I1/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Obesity (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

NO2019037C 2007-05-25 2019-10-16 pegvaliase NO2019037I1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11/807,227 US7534595B2 (en)	2006-06-12	2007-05-25	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
PCT/US2008/006661 WO2008153776A1 (en)	2007-05-25	2008-05-23	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using said compositions

Publications (1)

Publication Number	Publication Date
NO2019037I1 true NO2019037I1 (no)	2019-10-16

Family

ID=39868905

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO2019037C NO2019037I1 (no)	2007-05-25	2019-10-16	pegvaliase

Country Status (30)

Country	Link
US (1)	US7534595B2 (no)
EP (2)	EP2657335A1 (no)
JP (1)	JP5670183B2 (no)
KR (2)	KR20150038753A (no)
CN (1)	CN101842482B (no)
AR (2)	AR066716A1 (no)
AU (1)	AU2008263190B2 (no)
BR (1)	BRPI0811267B8 (no)
CA (1)	CA2687450C (no)
CL (1)	CL2008001497A1 (no)
CY (2)	CY1116894T1 (no)
DK (1)	DK2152868T3 (no)
EA (1)	EA018443B1 (no)
ES (1)	ES2551315T3 (no)
HK (1)	HK1135141A1 (no)
HR (1)	HRP20151268T1 (no)
HU (2)	HUE025784T2 (no)
IL (1)	IL202132A (no)
LT (1)	LTC2152868I2 (no)
LU (1)	LUC00133I2 (no)
MX (1)	MX2009012453A (no)
MY (1)	MY151413A (no)
NL (1)	NL301011I2 (no)
NO (1)	NO2019037I1 (no)
PE (1)	PE20090315A1 (no)
PL (1)	PL2152868T3 (no)
PT (1)	PT2152868E (no)
SI (1)	SI2152868T1 (no)
TW (1)	TWI418633B (no)
WO (1)	WO2008153776A1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7531341B1 (en)	2006-06-12	2009-05-12	Biomarin Pharmaceutical Inc.	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US7534595B2 (en) *	2006-06-12	2009-05-19	Biomarin Pharmaceutical Inc.	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US7560263B2 (en) *	2007-08-17	2009-07-14	Biomarin Pharmaceutical Inc.	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
US20110201022A1 (en) *	2008-07-30	2011-08-18	Biomarin Pharmaceutical Inc.	Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase
CA2782444C (en) *	2010-02-04	2018-10-23	Biomarin Pharmaceutical Inc.	Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
EP2877190B1 (en) *	2012-07-27	2016-11-02	University of North Texas	Genetically modified probiotic for the treatment of phenylketonuria (pku) disease
WO2014172541A2 (en) *	2013-04-18	2014-10-23	Codexis, Inc.	Engineered phenylalanine ammonia lyase polypeptides
JP6702866B2 (ja) *	2013-11-18	2020-06-03	ルビウスセラピューティクス，インコーポレイテッド	合成膜−レシーバー複合体
BR112016022814A8 (pt)	2014-04-01	2021-07-06	Rubius Therapeutics Inc	composição farmacêutica e seu método de preparação, ácido nucleico, e dispositivo médico ou kit médico
DK3145536T3 (da)	2014-04-16	2022-01-03	Codexis Inc	Modificeret tyrosinammoniaklyase
HRP20230468T1 (hr)	2014-12-22	2023-11-10	Codexis, Inc.	Varijante ljudske alfa galaktozidaze
TWI797060B (zh) *	2015-08-04	2023-04-01	美商再生元醫藥公司	補充牛磺酸之細胞培養基及用法
KR20230161535A (ko)	2016-07-26	2023-11-27	바이오마린 파머수티컬 인크.	신규 아데노-관련 바이러스 캡시드 단백질
ES2903263T3 (es) *	2016-08-30	2022-03-31	Mitsubishi Chem Corp	Método para producir enzima mutante y alcohol aciltransferasa mutante
CN106497905A (zh) *	2016-12-14	2017-03-15	江南大学	一株鱼腥藻来源的苯丙氨酸脱氨酶的突变体
CA3051262A1 (en) *	2017-02-13	2018-08-16	Codexis, Inc.	Engineered phenylalanine ammonia lyase polypeptides
CN107653275A (zh) *	2017-10-30	2018-02-02	安徽工程大学	D‑苯丙氨酸的制备方法
CN108004225B (zh) *	2017-12-19	2020-05-08	江南大学	一种成团泛菌来源的苯丙氨酸氨基变位酶的突变体
SG11202010830WA (en)	2018-05-09	2020-11-27	Biomarin Pharm Inc	Methods of treating phenylketonuria
TW202005978A (zh)	2018-05-14	2020-02-01	美商拜奧馬林製藥公司	新穎肝靶向腺相關病毒載體
WO2019241132A1 (en) *	2018-06-12	2019-12-19	Codexis, Inc.	Engineered tyrosine ammonia lyase
CA3105916A1 (en) *	2018-07-12	2020-01-16	Codexis, Inc.	Engineered phenylalanine ammonia lyase polypeptides
EP3893860A4 (en)	2018-12-14	2023-03-29	Codexis, Inc.	ENGINEERED TYROSINE AMMONIA LYASE
EA202191735A1 (ru)	2018-12-20	2021-11-24	Кодексис, Инк.	Варианты альфа-галактозидазы человека
CN110456056A (zh) *	2019-07-22	2019-11-15	浙江大学	一种新生儿苯丙酮尿症无创筛查试纸的制备方法
MX2022002473A (es)	2019-08-30	2022-08-02	Codexis Inc	Variantes de lipasa modificadas geneticamente.
IL294082A (en)	2019-12-20	2022-08-01	Codexis Inc	Transgenic variants of acid alpha-glycosidase
TW202144575A (zh)	2020-04-03	2021-12-01	美商拜奧馬林製藥公司	使用ａａｖ及治療調配物之苯酮尿症治療
US11767519B2 (en)	2020-08-28	2023-09-26	Codexis, Inc.	Engineered amylase variants
US11959108B2 (en)	2020-08-28	2024-04-16	Codexis, Inc.	Engineered protease variants
US11918633B2 (en) *	2021-05-19	2024-03-05	Biomarin Pharmaceutical Inc.	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating adolescent subjects
WO2023044381A1 (en) *	2021-09-16	2023-03-23	Arcturus Therapeutics, Inc.	Compositions and methods for treating phenylketonuria
CN117417925A (zh) *	2022-07-18	2024-01-19	浙江泽科塔生物医药有限公司	Pal变体、包含该pal变体的药物组合物以及用于制备该pal变体的方法
CN116478975B (zh) *	2023-06-16	2023-09-01	苏州优信合生技术有限公司	高活性苯丙氨酸解氨酶突变体及其表达菌株

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4252822A (en) *	1979-12-26	1981-02-24	Children's Hospital Medical Center	Method for treating phenylketonuria
US4562151A (en) *	1983-09-06	1985-12-31	Monsanto Company	Stabilization of L-phenylalanine ammonia-lyase enzyme
US5206344A (en) *	1985-06-26	1993-04-27	Cetus Oncology Corporation	Interleukin-2 muteins and polymer conjugation thereof
US5166322A (en)	1989-04-21	1992-11-24	Genetics Institute	Cysteine added variants of interleukin-3 and chemical modifications thereof
US5766897A (en) *	1990-06-21	1998-06-16	Incyte Pharmaceuticals, Inc.	Cysteine-pegylated proteins
ES2184756T3 (es) *	1992-11-19	2003-04-16	Anticancer Inc	Uso de metioninasa como agente antitumoral en quimioterapia antimetionina.
CA2149922C (en) *	1992-12-04	2007-05-15	Thomas W. Macallister	Genetically engineered glutaminase and its use in antiviral and anticancer therapy
DK75593D0 (no) *	1993-06-25	1993-06-25	Novo Nordisk As
AU702323B2 (en) *	1994-03-15	1999-02-18	Selective Genetics, Inc.	Heparin-binding growth factors for gene therapy and anterior eye disorders
WO1997011178A1 (en) *	1995-09-21	1997-03-27	Genentech, Inc.	Human growth hormone variants
CU22585A1 (es) *	1995-11-17	1999-11-03	Centro Inmunologia Molecular	Anticuerpos monoclonales antiidiótipos (ab2) de tipo igg con alta conectividad idiotípica y composiciones farmacéuticas que los contienen. su uso como inmunoreguladores de la respuesta inmune.
US6548644B1 (en) *	1997-03-10	2003-04-15	Immunex Corporation	Site protected protein modification
US6183738B1 (en) *	1997-05-12	2001-02-06	Phoenix Pharamacologics, Inc.	Modified arginine deiminase
US5981239A (en) *	1997-09-24	1999-11-09	Great Lakes Chemical Corp.	Synthesis of optically active phenylalanine analogs using Rhodotorula graminis
US7026446B1 (en) *	1997-12-24	2006-04-11	Diatech Pty Ltd.	Bifunctional molecules
TWI227241B (en) *	1998-06-20	2005-02-01	United Biomedical Inc	IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
US6451986B1 (en)	1998-06-22	2002-09-17	Immunex Corporation	Site specific protein modification
US6461849B1 (en) *	1998-10-13	2002-10-08	Novozymes, A/S	Modified polypeptide
US6403312B1 (en)	1998-10-16	2002-06-11	Xencor	Protein design automatic for protein libraries
US6686164B1 (en) *	1998-10-30	2004-02-03	Novozymes A/S	Low allergenic protein variants
AU772153B2 (en) *	1999-02-12	2004-04-08	Molecular Insight Pharmaceuticals, Inc.	Matrices for drug delivery and methods for making and using the same
CA2393688A1 (en) *	1999-12-09	2001-06-14	Chiron Corporation	Method for administering a cytokine to the central nervous system and the lymphatic system
US6586398B1 (en) *	2000-04-07	2003-07-01	Amgen, Inc.	Chemically modified novel erythropoietin stimulating protein compositions and methods
AU2001257032A1 (en) *	2000-04-14	2001-10-30	University Of South Carolina Research Foundation	Cloning, overexpression and therapeutic uses of bioactive histidine ammonia lyase
US6967097B2 (en) *	2000-07-24	2005-11-22	Pcbu Services, Inc.	Phenylalainine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
AU2001283496A1 (en) *	2000-07-25	2002-02-05	Immunomedics, Inc.	Multivalent target binding protein
US6897357B2 (en) *	2000-09-26	2005-05-24	Regents Of The University Of California	Characterization of phenylalanine ammonia-lyase (PAL) gene in wounded lettuce tissue
EP2343317A1 (en) *	2000-11-10	2011-07-13	F. Hoffmann-La Roche Ltd.	Apolipoprotein analogues
IL162811A0 (en)	2002-02-26	2005-11-20	Du Pont	Method for the recombination of genetic elements
JP4726483B2 (ja) *	2002-07-17	2011-07-20	サイトスバイオテクノロジーアーゲー	分子抗原アレイ
AU2003290780B2 (en)	2002-11-14	2009-05-07	The Scripps Research Institute	Crystalline form of fatty acid amine hydrolase (FAAH)
MXPA05013509A (es) *	2003-06-11	2006-04-05	Wyeth Corp	Polipeptidos de fusion de variante ib alfa de glucoproteina de plaquetas y metodos y uso de los mismos.
FR2868318B1 (fr) *	2004-04-01	2012-11-16	Commissariat Energie Atomique	Antigene tat stabilise et ses applications pour la vaccination anti-vih
US7670595B2 (en) *	2004-06-28	2010-03-02	Merck Patent Gmbh	Fc-interferon-beta fusion proteins
WO2006034373A2 (en)	2004-09-17	2006-03-30	Biomarin Pharmaceutical Inc.	Variants and chemically-modified variants of phenylalanine ammonia-lyase
CA2614769A1 (en) *	2005-03-10	2006-09-21	Verenium Corporation	Lyase enzymes, nucleic acids encoding them and methods for making and using them
US7534595B2 (en)	2006-06-12	2009-05-19	Biomarin Pharmaceutical Inc.	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US20090011400A1 (en)	2006-12-01	2009-01-08	The Salk Institute for Biological Studies and The Regents of the University of California	Substrate switched ammonia lyases and mutases
US7560263B2 (en) *	2007-08-17	2009-07-14	Biomarin Pharmaceutical Inc.	Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

2007
- 2007-05-25 US US11/807,227 patent/US7534595B2/en active Active
2008
- 2008-05-23 MY MYPI20094868 patent/MY151413A/en unknown
- 2008-05-23 KR KR20157007821A patent/KR20150038753A/ko not_active Application Discontinuation
- 2008-05-23 HU HUE08754717A patent/HUE025784T2/en unknown
- 2008-05-23 JP JP2010509405A patent/JP5670183B2/ja active Active
- 2008-05-23 CL CL2008001497A patent/CL2008001497A1/es unknown
- 2008-05-23 PT PT87547170T patent/PT2152868E/pt unknown
- 2008-05-23 EP EP13169362.4A patent/EP2657335A1/en not_active Withdrawn
- 2008-05-23 TW TW097119178A patent/TWI418633B/zh active
- 2008-05-23 EA EA200970980A patent/EA018443B1/ru unknown
- 2008-05-23 ES ES08754717.0T patent/ES2551315T3/es active Active
- 2008-05-23 DK DK08754717.0T patent/DK2152868T3/en active
- 2008-05-23 WO PCT/US2008/006661 patent/WO2008153776A1/en active Application Filing
- 2008-05-23 SI SI200831540T patent/SI2152868T1/sl unknown
- 2008-05-23 CA CA2687450A patent/CA2687450C/en active Active
- 2008-05-23 EP EP08754717.0A patent/EP2152868B1/en active Active
- 2008-05-23 MX MX2009012453A patent/MX2009012453A/es active IP Right Grant
- 2008-05-23 PL PL08754717T patent/PL2152868T3/pl unknown
- 2008-05-23 CN CN200880016898.4A patent/CN101842482B/zh active Active
- 2008-05-23 AR ARP080102198A patent/AR066716A1/es active IP Right Grant
- 2008-05-23 PE PE2008000889A patent/PE20090315A1/es active IP Right Grant
- 2008-05-23 AU AU2008263190A patent/AU2008263190B2/en active Active
- 2008-05-23 BR BRPI0811267A patent/BRPI0811267B8/pt active IP Right Grant
- 2008-05-23 KR KR1020097027018A patent/KR101603796B1/ko active IP Right Grant
2009
- 2009-11-15 IL IL202132A patent/IL202132A/en active IP Right Grant
2010
- 2010-04-01 HK HK10103366.8A patent/HK1135141A1/zh unknown
2015
- 2015-11-06 CY CY20151100997T patent/CY1116894T1/el unknown
- 2015-11-24 HR HRP20151268TT patent/HRP20151268T1/hr unknown
2018
- 2018-01-17 AR ARP180100106A patent/AR110834A2/es unknown
2019
- 2019-10-09 NL NL301011C patent/NL301011I2/nl unknown
- 2019-10-10 LT LTPA2019517C patent/LTC2152868I2/lt unknown
- 2019-10-14 LU LU00133C patent/LUC00133I2/fr unknown
- 2019-10-16 NO NO2019037C patent/NO2019037I1/no unknown
- 2019-10-17 CY CY2019039C patent/CY2019039I1/el unknown
- 2019-10-18 HU HUS1900049C patent/HUS1900049I1/hu unknown

Also Published As

Publication number	Publication date
EP2152868B1 (en)	2015-09-02
CY2019039I2 (el)	2020-05-29
NL301011I2 (nl)	2020-05-13
CA2687450A1 (en)	2008-12-18
IL202132A0 (en)	2010-06-16
PL2152868T3 (pl)	2016-01-29
LUC00133I2 (no)	2020-07-16
US7534595B2 (en)	2009-05-19
KR101603796B1 (ko)	2016-03-17
AR110834A2 (es)	2019-05-08
JP5670183B2 (ja)	2015-02-18
DK2152868T3 (en)	2015-11-16
PT2152868E (pt)	2015-11-13
KR20150038753A (ko)	2015-04-08
CY2019039I1 (el)	2020-05-29
CA2687450C (en)	2019-03-26
CL2008001497A1 (es)	2009-01-09
CY1116894T1 (el)	2017-04-05
HRP20151268T1 (hr)	2015-12-18
HK1135141A1 (zh)	2010-05-28
TWI418633B (zh)	2013-12-11
KR20100024437A (ko)	2010-03-05
TW200902052A (en)	2009-01-16
AU2008263190B2 (en)	2014-04-17
IL202132A (en)	2017-06-29
LUC00133I1 (no)	2019-10-16
MX2009012453A (es)	2010-01-25
HUE025784T2 (en)	2016-05-30
BRPI0811267B8 (pt)	2021-05-25
WO2008153776A8 (en)	2009-07-30
AU2008263190A1 (en)	2008-12-18
EP2152868A1 (en)	2010-02-17
JP2010529835A (ja)	2010-09-02
LTC2152868I2 (lt)	2020-09-25
AR066716A1 (es)	2009-09-09
SI2152868T1 (sl)	2015-12-31
WO2008153776A1 (en)	2008-12-18
HUS1900049I1 (hu)	2019-11-28
LTPA2019517I1 (lt)	2019-10-25
MY151413A (en)	2014-05-30
CN101842482A (zh)	2010-09-22
EP2657335A1 (en)	2013-10-30
NL301011I1 (nl)	2019-10-16
PE20090315A1 (es)	2009-03-19
US20080008695A1 (en)	2008-01-10
EA200970980A1 (ru)	2010-04-30
CN101842482B (zh)	2014-10-22
BRPI0811267A2 (pt)	2014-10-07
BRPI0811267B1 (pt)	2020-11-10
ES2551315T3 (es)	2015-11-18
EA018443B1 (ru)	2013-08-30

Publication	Publication Date	Title
NO2019037I1 (no)	2019-10-16	pegvaliase
DE602008006301D1 (de)	2011-06-01	Koaxialnadelanordnung
BRPI0821573A2 (pt)	2016-08-09	benzofuropirimidonas
ATE501136T1 (de)	2011-03-15	Imidazopyridinone
DK2159224T3 (da)	2012-08-20	Bromphenylsubstituerede thiazolyldihydropyrimidiner
ATE514696T1 (de)	2011-07-15	Diphenyl-dihydro-imidazopyridinone
DE602008002772D1 (de)	2010-11-11	Polyvinylpyrrolidonpulverzusammensetzungen
DE112008003636A5 (de)	2010-10-21	Mehrzuggruppierer
DE502007001207D1 (de)	2009-09-10	Elektrosaugkopf
BRPI0814519A2 (pt)	2014-09-30	Organopolissiloxano
BRPI0811451A2 (pt)	2014-11-04	Exopolissacarídeo
BRPI0812840A2 (pt)	2014-12-09	2-imidazolinas
DE602008000749D1 (de)	2010-04-15	Buschschneider
DE602008000923D1 (de)	2010-05-20	Einzelwaferätzgerät
AT505058A3 (de)	2008-12-15	Türschliesssystem
BRPI0815547A2 (pt)	2015-02-10	Depsipeptídeos cícliocos
DE602008004695D1 (de)	2011-03-10	Katalysatorträgerwabe
BRPI0812994A2 (pt)	2014-12-23	Microbiocidas
DE602008001234D1 (de)	2010-06-24	Bandmaterialzuführvorrichtung
DE602008005950D1 (de)	2011-05-19	Münzvereinzeler
DE602008005589D1 (de)	2011-04-28	Rliganden
DE602008001674D1 (de)	2010-08-19	Wimpernwickler
DE112008003094A5 (de)	2010-08-12	Geomatte
DE502008003063D1 (de)	2011-05-19	Magnetventilinjektor
DE112008003196A5 (de)	2011-02-03	Handpipettiergerät